CoChat

The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity

Open access
Ampuero, Javier, Aller, Rocío, Gallego‐Durán, Rocío, Banales, Jesus M., Crespo, Javier, García‐Monzón, Carmelo, Pareja, María Jesús, Vilar‐Gómez, Eduardo, Caballería, Juan, Escudero‐García, Desamparados, Gomez‐Camarero, Judith, Calleja, José Luis, Latorre, Mercedes, Albillos, Agustín, Salmeron, Javier, Aspichueta, Patricia, Lo Iacono, Oreste, Francés, Rubén, Benlloch, Salvador, Fernández‐Rodríguez, Conrado, García‐Samaniego, Javier, Estévez, Pamela, Andrade, Raúl J., Turnes, Juan, Romero‐Gómez, Manuel, HEPAmet Registry · 2018 · Alimentary Pharmacology & Therapeutics
Cited by 106

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Background: Metabolically healthy obesity (MHO) shows a reduced risk compared with obese patients with adverse metabolic conditions. Lean people suffering some metabolic derangements also have non‐alcoholic fatty liver disease (NAFLD)‐related outcomes compared with non‐obese subjects with a few metabolic risks. Aim: To define the impact of the metabolic status on the NAFLD‐related outcomes, beyond the presence of obesity. Methods: We designed a multicentre cross‐sectional study, including 1058 biopsy‐proven NAFLD patients. Metabolically healthy status was strictly defined by the lack of metabolic risk factors (diabetes mellitus, low HDL, hypertriglyceridemia, arterial hypertension). Non‐alcoholic steatohepatitis (NASH) and significant fibrosis (F2‐F4) were identified by liver biopsy. Chronic kidney disease epidemiology collaboration equation was calculated for kidney function and the atherogenic index of plasma (AIP) for cardiovascular risk. Results: Metabolically healthy (OR 1.88; P = 0.050) and unhealthy obesity (OR 3.47: P < 0.0001), and unhealthy non‐obesity (OR 3.70; P < 0.0001) were independently associated with NASH together with homeostatic model assessment (HOMA), ALT, and platelets. Significant fibrosis was more frequently observed in the presence of adverse metabolic conditions in obese (OR 3.89; P = 0.003) and non‐obese patients (OR 3.92; P = 0.002), and independently associated with platelets, albumin, ALT, HOMA, and age. The number of metabolic factors determined the risk of NASH and significant fibrosis. Glomerular filtration rate was lower in unhealthy (91.7 ± 18) than healthy metabolism (95.6 ± 17) (P = 0.007). AIP was higher in adverse metabolic conditions (P = 0.0001). Metabolically unhealthy non‐obesity showed higher liver damage (NASH 55.8% vs 42.4%; P < 0.05; significant fibrosis 31.7% vs 11.4%; P < 0.0001) and cardiovascular risk (P < 0.0001) than healthy obesity. Conclusions: Metabolic unhealthy status showed a greater impact on NASH, significant fibrosis, kidney dysfunction, and atherogenic profile than obesity. However, metabolically healthy obesity was not a full healthy condition. We should focus our messages especially on patients with adverse metabolic conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.15015

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 106

Metadata

Authors
Ampuero, J., Aller, R., Gallego‐Durán, R., Banales, J. M., Crespo, J., García‐Monzón, C., Pareja, M. J., Vilar‐Gómez, E., Caballería, J., Escudero‐García, D., Gomez‐Camarero, J., Calleja, J. L., Latorre, M., Albillos, A., Salmeron, J., Aspichueta, P., Lo Iacono, O., Francés, R., Benlloch, S., Fernández‐Rodríguez, C., García‐Samaniego, J., Estévez, P., Andrade, R. J., Turnes, J., Romero‐Gómez, M., & HEPAmet Registry
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2018-10-23
Volume
48
Issue
11-12
Pages
1260-1270
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2898557836
Cited by
106
References
5
FWCI
7.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity. https://app.cochat.ai/papers/10.1111/apt.15015
The paper
Ampuero, J., Aller, R., Gallego‐Durán, R., Banales, J. M., Crespo, J., García‐Monzón, C., Pareja, M. J., Vilar‐Gómez, E., Caballería, J., Escudero‐García, D., Gomez‐Camarero, J., Calleja, J. L., Latorre, M., Albillos, A., Salmeron, J., Aspichueta, P., Lo Iacono, O., Francés, R., Benlloch, S., . . . HEPAmet Registry. (2018). The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.15015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.